Cel-Sci Corporation (CVM) earnings
CVM earnings moved a median of +0.74% by the close. Quarterly and annual CVM reports and results, each read against the price at its own news timestamp. Back to the CVM overview →
18 measured CVM earnings events.
Where these CVM earnings landedvs 18 measured CVM earnings reactions
| Middle 50% of CVM earnings reactions | -2.44% to +7.12% |
|---|---|
| Median reaction (to close) | +0.74% |
| Measured reactions | 18 |
Point-in-time · zero look-ahead
Half of the 18 CVM earnings events with a measured close landed between -2.44% and +7.12%; 50% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| CEL-SCI Reports Fiscal Third Quarter 2026 Results | Press release | -2.19% | -3.13% | |
| Form 10-Q CEL SCI CORP For: Jun 30 | SEC filing · Form 10-Q | -2.19% | -3.13% | |
| CEL-SCI Reports Fiscal Second Quarter 2026 Results | Press release | +0.00% | +15.44% | |
| Form 10-Q CEL SCI CORP For: Mar 31 | SEC filing · Form 10-Q | +0.00% | +15.44% | |
| CEL-SCI Reports Fiscal First Quarter 2026 Results | Press release | +0.00% | +7.25% | |
| Form 10-Q CEL SCI CORP For: Dec 31 | SEC filing · Form 10-Q | +0.00% | +7.25% | |
| Form 10-K CEL SCI CORP For: Sep 30 | SEC filing · Form 10-K | +4.13% | +9.96% | |
| CEL-SCI Reports Fiscal Third Quarter 2025 Financial Results | Press release | +0.36% | +4.63% | |
| Form 10-Q CEL SCI CORP For: Jun 30 | SEC filing · Form 10-Q | +2.87% | +1.50% | |
| CEL-SCI Reports Fiscal Second Quarter 2025 Financial Results | Press release | -7.76% | -7.44% | |
| Form 10-Q CEL SCI CORP For: Mar 31 | SEC filing · Form 10-Q | -7.76% | -7.44% | |
| Form 10-Q CEL SCI CORP For: Dec 31 | SEC filing · Form 10-Q | -5.79% | +6.75% | |
| Form 10-K CEL SCI CORP For: Sep 30 | SEC filing · Form 10-K | -0.73% | +1.48% | |
| Form NT 10-K CEL SCI CORP For: Sep 30 | SEC filing · Form NT | -0.07% | -2.56% | |
| Form 10-Q CEL SCI CORP For: Jun 30 | SEC filing · Form 10-Q | +0.02% | +0.00% | |
| Form 10-Q CEL SCI CORP For: Mar 31 | SEC filing · Form 10-Q | -0.70% | -2.10% | |
| Form 10-Q CEL SCI CORP For: Dec 31 | SEC filing · Form 10-Q | +1.68% | -0.84% | |
| Form 10-K CEL SCI CORP For: Sep 30 | SEC filing · Form 10-K | -0.72% | -0.72% |
Keep exploring
More CVM: analyst actions → · SEC filings → · CVM overview →
Other Healthcare names and their earnings
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| Y-mAbs Therapeutics, Inc. (YMAB) | 226 | -0.20% | 39% |
| Aurinia Pharmaceuticals Inc - Common Shares (AUPH) | 224 | +0.13% | 54% |
| OraSure Technologies, Inc. (OSUR) | 224 | -0.17% | 45% |
| Phibro Animal Health Corporation - Class A (PAHC) | 224 | -0.22% | 45% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its earnings — that is what the link opens.